Testing version — LOERadar is in active testing. Features and data may change.

ROSIGLITAZONE MALEATE AND GLIMEPIRIDE (GLIMEPIRIDE; ROSIGLITAZONE MALEATE) | LOERadar

Viewing data from:

ROSIGLITAZONE MALEATE AND GLIMEPIRIDE

ANDA

GLIMEPIRIDE; ROSIGLITAZONE MALEATE | A078709 | TEVA PHARMACEUTICALS USA

5 strengths0 unique patents0 unique exclusivities

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Apr 5, 2016	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (5)

Sort:

#001 — 1MG;4MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Apr 1, 2016

No patent or exclusivity listings for this strength.

#002 — 2MG;4MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 1, 2016

#003 — 4MG;4MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 1, 2016

#004 — 2MG;8MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 1, 2016

#005 — 4MG;8MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 1, 2016